Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Neurofibrosarcoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1

Interventions

Radiotherapy 10Vincristine 9Dactinomycin 8Cyclophosphamide 8Radiation 6Ifosfamide 6Doxorubicin 5Irinotecan 4Filgrastim 4Etoposide 4Vinorelbine 3sargramostim 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2Biopsy 2trofosfamide 1trioctyl phosphine oxide 1temsirolimus 1pegfilgrastim 1etoposide phosphate 1X-Rays 1Topotecan 1Surgical Procedures, Operative 1Spinal Puncture 1Sirolimus 1Sentinel Lymph Node Biopsy 1Phantoms, Imaging 1Idarubicin 1Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Rhabdomyosarcoma × Combined Modality Therapy × Clear all
NCT00061984 2014-10-27

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
455 enrolled
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡